Hyperfine (HYPR) Asset Utilization Ratio (2021 - 2026)

Hyperfine (HYPR) posted Asset Utilization Ratio of 0.27 for Q1 2026, down 5.39% on a QoQ basis from 0.28 in Q4 2025, and up 26.9% year-over-year from 0.21 in Q1 2025.

Hyperfine (HYPR) Asset Utilization Ratio (2021 - 2026) Analysis & Trends

Hyperfine's Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.27 for Q1 2026.

  • Quarterly Asset Utilization Ratio rose 26.9% year-over-year to 0.27 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.27 (up 26.9% YoY) and the FY2025 annual result came in at 0.24, up 41.11% from the prior year.
  • Asset Utilization Ratio was 0.27 for Q1 2026 at Hyperfine, down from 0.28 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.28 in Q4 2025 and bottomed at 0.01 in Q1 2022.
  • A 5-year average of 0.14 and a median of 0.13 in 2024 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2022 — Asset Utilization Ratio surged 562.0% — and 2026, when it gained 26.9%.
  • Hyperfine's Asset Utilization Ratio stood at 0.05 in 2022, then soared by 131.76% to 0.11 in 2023, then soared by 79.66% to 0.2 in 2024, then surged by 39.49% to 0.28 in 2025, then dropped by 5.39% to 0.27 in 2026.
  • Business Quant data shows HYPR's Asset Utilization Ratio at 0.27 in Q1 2026, 0.28 in Q4 2025, and 0.24 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 0.46
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 0.54
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 0.39
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 0.47
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 0.47
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 0.74
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 0.65
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 0.57
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Hyperfine 92.81 Mn 51.53 Mn 1.98 Mn 0.27

Historic Data

Download Data
DateValue
Mar 31, 2026 0.27
Dec 31, 2025 0.28
Sep 30, 2025 0.24
Jun 30, 2025 0.22
Mar 31, 2025 0.21
Dec 31, 2024 0.20
Sep 30, 2024 0.18
Jun 30, 2024 0.15
Mar 31, 2024 0.13
Dec 31, 2023 0.11
Sep 30, 2023 0.09
Jun 30, 2023 0.08
Mar 31, 2023 0.06
Dec 31, 2022 0.05
Sep 30, 2022 0.04
Jun 30, 2022 0.02
Mar 31, 2022 0.01
Dec 31, 2021 0.01